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1Stereodivergent routes in organic synthesis: 
Carbohydrates, amino acids, alkaloids and 
terpenes
Carmen Nájera,a* Francisco Foubelo,a,b,c José M. Sansanoa,b,c and Miguel Yusa
The natural occurrence of enantio- and diastereomers is often encountered. In addition, the 
synthesis of these stereoisomers is important for structure determination and for the study of 
structure-activity-relationships. Stereodivergent routes simplify the access to these molecules 
starting from a common material. This review is focused on the synthesis of carbohydrates, amino 
acids, alkaloids and terpenes using this efficient strategy. In the case of carbohydrates, such as 
monosaccharides, carbasugars, aminosugars and azasugars, carbohydrates are usually 
employed as common starting materials. As a very common strategy, configurations of hydroxy 
groups are inverted by SN2 methods playing with protection and deprotection processes. For the 
synthesis of acyclic α-AAs diastereoselective methods using mainly Garner’s aldehyde have been 
described. Diastereodivergent routes allowed the synthesis of β-hydroxy- and β-amino-α-amino 
acids, as well as of β- and γ-amino acids. Heterocyclic and cyclic amino phosphonic acids were 
synthesized using diastereodivergent routes. Alkaloids containing five- and six-membered 
saturated azaheterocycles needed multistep stereodivergent routes as well as other alkaloids, 
such as enantiomers of balanol, vincamine, anatoxin and codeine and diastereomeric 
isochaetominines C and galanthamines. In the terpene field, sesquiterpenes β-santalene, α-
curcumene and α-cuparenone and the diterpene scopadulcic acid A were synthesized using 
enantiodivergent routes.
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21. Introduction
The control of the regio- and stereochemistry in synthetic processes is a fundamental issue 
for the preparation of organic molecules. In order to access to different regio- and 
stereoisomers starting from the same substrate, efficient regiodivergent1 and 
stereodivergent2 catalytic methodologies have been developed. An alternative strategy is 
the development of stereodivergent multistep routes focused on the asymmetric synthesis 
of enantiomeric or/and diastereomeric natural products and other bioactive compounds 
also from the same starting material. In this review article, selective stereodivergent 
pathways (without stereoisomers separation) to give stereoisomeric products such as 
carbohydrates, amino acids, alkaloids and terpenes will be covered. Since both 
enantiomers of different diastereomers are often found in several groups of natural 
products and in bioactive molecules, minor but also major changes must be done in the 
synthetic routes. Processes involving separation of enantiomers or diastereomers will be 
not considered as stereodivergent routes.
2. Carbohydrates
2.1 Monosacharides
Diastereomeric divergent routes to the 2,6-dideoxyhexoses L-cymarose and L-sarmentose 
have been described by Brasholz and Reiβig.3 Starting from a ribo-configured 
pyranoside, which was initially prepared from O-trityl-(S)-α-hydroxypropanal and 1-
lithio-1-methoxyallene, by hydrolysis with aqueous HCl gave L-cymarose in 54% yield 
(Scheme 1). Alternatively, this pyranoside was epimerized to the corresponding acetate 
by mesylation and SN2 reaction with CsOAc in the presence of 10-crown-6 and by 
subsequent acetate deprotection and hydrolysis free L-sarmentose was obtained. In this 
case, just an inversion of the configuration of the carbon atom bearing the hydroxy group 
at the 4-position of the pyranoside gave the other diastereomer.
O
OMe
OiPr
HO
HCl, H2O
O
OMe
HO
OH
i. MsCl, Py
ii. CsOAc, 18-crown-6, DMF
O
OMe
OiPr
AcO
i. DIPEA, MeOH
ii. HCl, THF
O
OMe
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OH
L-cymarose, 54%
L-sarmentose, 67%
Scheme 1  Diastereodivergent synthesis of L-cymarose and L-sarmentose.
Enantiodivergent routes to D,D- and L,L-glycero-β-allo-heptopyranoses from 2,2-
dioxan-5-one have been reported by Majewski and co-workers.4 This dioxanone was 
transformed by aldol condensation into a deprotected dialdehyde, which is the common 
precursor of both enantiomers of glycero-allo-heptose (Scheme 2). Dithiane hydrolysis 
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3of this compound using Corey’s protocol (NBS/AgNO3)5 gave the corresponding 
aldehyde, which was reduced to the expected alcohol. Subsequent deprotection of the 
acetal and the TBS group afforded a pyranoside, which was further acetylated, 
debenzylated and acetylated again to provide the hexaacetate of D-glycero-β-D-allo-
heptopyranose in 22% overall yield. For the L-enantiomer, a similar approach was 
performed, the main difference being the intramolecular acetalyzation of the aldehyde 
from the dithiane protection with the OH group at the 5-position giving a 14/86 mixture 
of separable α/β epimers. Final debenzylation and acetylation gave the hexaacetate L-
glycero-β-L-allo-heptopyranose in 20% overall yield.
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Scheme 2  Enantiodivergent synthesis of glycero-allo-heptoses
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4Noviose, a rare sugar present in many biologically active molecules such as 
novobiocin and tiacumicin, has been prepared by an enantiodivergent strategy to access 
both antipodes from ()-pantolactone by Reddy and co-workers.6 ()-Pantolactone was 
transformed into the common intermediate, in which one allylic alcohol was protected as 
benzyl ether. Dihydroxylation of the benzyl silyl ether and treatment with triphosgene 
gave the corresponding carbonate (Scheme 3). Debenzylation followed by methylation 
and desilylation provided the alcohol, which was oxidized by PDC and subjected to 
Baeyer-Williger oxidation to give the corresponding lactone, which was reduced using 
DIBALH7 to afford ()-noviose. For the preparation of its (+)-enantiomer, the benzyl 
methyl ether was submitted to a similar route.
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Scheme 3  Enantiodivergent routes for the synthesis of ()- and (+)-noviose.
2.2 Carbasugars
Monosacharides, in which a methylene group replaces the endocyclic oxygen are named 
carbasugars, are the most important class of glycomimetics. Natural and synthetic 
carbasugars have shown interesting biological activities mainly as antibiotics and 
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6glycosidase inhibitors.8 Enantio- and diastereodivergent syntheses of conduritols were 
described by Takano9 and Weinreb10 groups, respectively. Based on different protecting 
groups, the synthesis of both ()- and (+)-conduritol C has been carried out from the Diels-
Alder adduct allylic alcohol resulting from a lipase PS mediated resolution of the 
precursor meso-diol. This alcohol was protected by MOMCl, and then the acetate was 
hydrolyzed to a hydroxy group of the precursor of (-conduritol C (Scheme 4).9 
Enantiodivergently, silyl protection and hydrolysis of the acetate group, followed by 
MOM protection and desilylation, afforded the precursor of (+)-conduritol C.
OAc
HO
i. MOMCl, DIPEA, DCM
ii. K2CO3, MeOH, rt
i. TBSCl, Im, DMF, rt
ii. K2CO3, MeOH, rt
iii. MOMCl. DIPEA, DCM, rt
iv. TBAF, THF,rt
OH
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OMOM
HO
<88%
74%
OH
OH
OH
OH
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OH
OH
OH
()-conduritol C
(+)-conduritol C
Scheme 4  Enantiodivergent routes to conduritol C precursors.
An unexpected cyclization of a racemic vinylsilane-aldehyde took place in a 
diastereodivergent manner depending on the Lewis acid used.10 In the case of SnCl4 or 
BF3·OEt2 two diastereomeric trimethylated cyclitols were obtained (Scheme 5). The 
formation of the 1,2-syn isomer has been explained via a chelated chair-like transition 
state I induced by SnCl4. However, using a nonchelating Lewis acid such as BF3·OEt2 a 
complexation with the carbonyl group in transition state II can take place.
TMS
OMe
OMe
OMe
O
H
SnCl4, DCM
-78 ºC to rt
BF3·OEt2
rt
O
H
MeO
MeO
MeO
SiMe3
SnCl4
I
H
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MeO
MeO
SiMe3
II
BF3
OMe
OMe
OH
OMe
OMe
OMe
OH
OMe
68%, dr > 30:1
86%, dr >30:1
Scheme 5  Diastereodivergent routes to trimethylated conduritols.
Pinitol, the monomethylated inositol, occurred in various plant sources with both 
enantiomers. Hudlicky and co-workers11 reported an efficient enantiodivergent synthesis 
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7of (+)-and ()-pinitol from a common chiral diene prepared by microbial oxidation of 
bromobenzene by Pseudomonas putida 39-D.12 Initial osmylation of the more electron-
rich double bond, followed by dehalogenation, epoxidation and ring opening, gave ()-
pinitol (Scheme 6). On the other hand, epoxidation of the same double bond followed by 
methanolysis afforded a cyclohexene intermediate, which was osmylated to a diol 
providing ()-pinitol after the final acetal deprotection.
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OH
(+)-pinitol, 90% (-pinitol, 63%
Scheme 6  Enantiodivergent routes to (+)- and ()-pinitol.
Natural (+)-cyclophellitol has higher potency than castanospermine or norjirimycin 
as glycosidase inhibitor. Racemic cyclophellitol and (1R*,6S*)-cyclophellitol have been 
synthesized by the Arjona and Plumet group.13 The diastereodivergent synthesis has been 
performed starting from a differently protected cyclohexenediol to control the key 
epoxidation step. The dibenzylated cyclohexenediol was treated with MCPBA and then 
deprotected to (±)-cyclophellitol, which was isolated and characterized as its tetraacetyl 
derivative in 80% yield after these two steps (Scheme 7). Whereas, the p-methoxybenzyl 
protected cyclohexenediol was disilylated and after PMB-deprotection with DDQ it was 
submitted to epoxidation and final desilylation giving diastereomeric (1R*,6S*)-
cyclophellitol, which was also isolated as tetraacetate in 75% yield after the last two steps.
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Scheme 7  Diastereodivergent routes to (±)-cyclophellitol and its (1R*,6S*)-diastereomer.
Three different carbasugars have been prepared by the Gómez and López group14 
starting from D-mannose based on a radical cyclization. The common intermediate is a 
polyhydroxylated exo-methylenecyclohexanone derivative. In the case of 5a-carba-α-D-
galactose pentaacetate, the alkene was submitted to ozonolysis and reduction at C-5 
affording the corresponding diol, which was further benzylated and the acetal group 
hydrolyzed. Silylation of the primary hydroxy group was followed by transforming it into 
the corresponding xanthate, which led to a 5a-carbagalactose derivative by treatment with 
tri-n-butyltin hydride. Conventional deprotection steps, followed by acetylation, yielded 
the corresponding tetraacetate (Scheme 8). For the preparation of 5a-carba-β-L-gulose 
pentaacetate the starting alkene was benzylated at 1-OH and submitted to ozonolysis and 
reduction with moderate diastereoselectivity (3:1 mixture). Deoxygenation provided a 
gulose derivative, which was submitted to common deprotection steps and acetylation to 
give the final tetraacetate. The synthetic route for 5a-carba-D-glucose implied inversion 
in the 5a-OH group and deoxygenation at C-4. Initial benzylation of the 1-OH, followed 
by selective deprotection of the acid labile primary isopropylidene acetal and by silyl 
protection of 6-OH, allowed selective deoxygenation at C-4. Further ozonolysis-
reduction gave the desired isomer with moderate diastereoselectivity (2.5:1). 
Conventional deprotection steps and acylation provided the glucose derivative (Scheme 
8).
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Scheme 8  Diastereodivergent routes to 5a-carba-α-D-galactose, 5a-carba-β-L-gulose and 5a-
carba-α-D-glucose pentaacetates.
Diastereomeric carba-analogues of glycal-derived vinyl epoxides have been 
prepared from tri-O-acetyl-D-glucal by Di Bussolo and co-workers.15 The common 
intermediate trans diol, obtained from the glucal derivative, was selectively 
monosilylated and mesylated (Scheme 9). Further desilylation and cyclization provided 
the ()-2β-epoxide in 62% overall yield. Whereas, mesylation of the allylic hydroxyl 
group followed by base treatment afforded the ()-2α-epoxide in 82% yield.
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Scheme 9  Diastereodivergent routes to carba-analogues of D-galactal and D-allal-derived vinyl 
epoxides.
A stereodivergent synthesis of 4-membered carbasugars has been carried out from 
vitamin C by Compain and co-workers.16 Diastereomeric carbasugars were prepared from 
a common intermediate 2,3-dibenzylated 4-silylated cyclobutylmethanol. This substrate 
was stepwise deprotected to the carbaoxetanose (1R, 2r, 3S, 4s)-4-
(hydroxymethyl)cyclobutane-1,2,3-triol in quantitative yield (Scheme 10). On the other 
hand, benzylation of the primary alcohol followed by desilylation and oxidation with 
Dess-Martin periodinane (DMP) provided the corresponding ketone, which was reduced 
with L-Selectride giving the epimeric alcohol. Final deprotection by hydrogenolysis 
afforded cyclobutanic pseudogalactose (1S,2R,3s,4s)-4-(hydroxymethyl)cyclobutane-
1,2,3-triol.
OBn
TBSO
BnO
OH
i. NaH, BnBr, THF
ii. TBAF, THF
iii. DMP, DCM
TBAF, THF
OBn
HO
BnO
OH
quant
H2, HCO2H, Pd/C, EtOH
i. L-selectride, THF, -78 ºC
ii. H2, HCO2H, Pd/C, EtOH
OBn
O
BnO
OBn
59%
OH
HO
HO
OH
OH
HO
HO
OH
quant
67%
Scheme 10  Diastereodivergent routes to 4-membered carbasugars.
2.3 Aminosugars
Conduramines are aminocyclohexenetriols that also have significant glycosidase 
inhibitory activity being synthetic precursors of amino- and diaminocyclitols. Riera and 
co-workers17 have described a diastereodivergent synthesis of cis- and trans-isomers of 
an oxazolidine alcohol, as building blocks for the synthesis of all isomers of 
deoxyconduramines, and after dihydroxylation of the double bond to aminocyclitols. 
Starting from a β-amino alcohol with the anti-configuration cis-oxazolidine was 
synthesized by reaction with 2,2-dimethoxypropane and desilylation (Scheme 11). For 
the trans-isomer the amino alcohol was submitted to Mitsunobu conditions and reduction 
to give the syn-amino alcohol, which was treated under the same reaction conditions to 
afford the trans-oxazolidine alcohol.
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OHMe2C(OMe)2
PTSA
i. PPh3, DIAD, 4-O2NC6H4CO2H
ii. RedAl, DCM
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96% 65%
cis-oxazolidine alcohol trans-oxazolidine alcohol
Scheme 11  Diastereodivergent routes to oxazolidine alcohols precursors of deoxyconduramines 
and aminocyclitols.
Based on diastereodivergent reduction of β-azido alcohols the Park and Rhee group 
reported the synthesis of 3,4,6-trideoxy-3-amino sugars.18 The common 3-azido 
carbohydrate was treated with MOMCl to protect the 2-OH and then the azido group was 
reduced by Ru catalysis under photolytic conditions to the corresponding imine and then 
LiAlH4 was added to produce the 2-MOM-protected (2R,3R)-isomer (Scheme 12). 
Whereas, by Pd-catalyzed hydrogenation the (2R,3S)-amino sugar was prepared. A new 
class of iminosugars has been recently reported by Compain and co-workers.19
O
N3
OCy
OH
i. NaH, MOMBr
ii. [Ru] (4 mol%), then LAH
H2, Pd/C
O
NH2
OCy
OMOM
O
NH2
OCy
OH
59%
88%
Ru
Ru
O
O
OC CO
Ph
ArNH
Ph
Ph
Ph
ArNH
[Ru] (Ar = 2-FC6H4)
Scheme 12  Diastereodivergent route to 3,4,6-trideoxy-3-amino sugars.
Polyhydroxylated bicyclic azetidines have been diastereodivergently prepared from 
the same 6-aza-bicyclo[3.2.0]heptane derivative. Initial dihydroxylation, followed by 
perbenzylation of the four hydroxy groups and subsequent reduction with AlH2Cl and 
Page 12 of 87Organic & Biomolecular Chemistry
12
reductive debenzylation the corresponding bicyclic iminosugar was obtained (Scheme 
13). On the other hand, epoxidation and further benzylation gave the epoxide, which was 
opened with AcOH and acetylated. Final carbonyl reduction and Pd-catalyzed 
hydrogenation afforded the bicyclic analogue of 1-deoxygulonojirimycin. 
BnN
HO
HO
OBn
i. MCPBA, DCM, rt
ii. NaH,BnBr, 0 ºC to rt
OsO4, NMO, Me2CO
H2O, 0 ºC to rt
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80% 65%
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i. H2SO4, AcOH
ii. Ac2O, Py
NaH, BnBr, DMF
0 ºC to rt
BnN
HO
BnO
OBn
OBn
OBn
BnN
HO
BnO
OBn
OAc
OAc
85% 78%
i. AlH2Cl,Et2O
ii. H2, Pd(OH)2/C
HCl, H2O, THF, IPA
i. AlH2Cl, Et2O
ii. H2, Pd(OH)2/C
HCl, H2O, THF, IPA
HN
H
HO
OH
OH
OH
HN
H
HO
OH
OH
OH
72% 68%
Scheme 13  Diastereodivergent route to polyhydroxylated bicyclic azetidines.
Enantiodivergent routes to 4,4’-difluoro analogue of 5’-noraristeromycin, a 
potential antiviral drug, have been carried out by Schneller and co-workers.20 From (+)-
(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate21 the carbocyclic nuceloside22 was 
prepared, which was oxidized to a ketone (Scheme 14). The incorporation of the geminal 
difluoro moiety was performed with diethylaminosulfur trifluoride (DAST), which by 
ammonolysis and final deprotection with Dowex, provided ()-5-(6-amino-9H-purin-9-
yl)-3,3-difluorocyclopentane-1,2-diol. For the preparation of its enantiomer the starting 
material was submitted to Mitsunobu conditions using dichloroacetic acid in order to 
invert the configuration of the hydroxyl group. A second Mitsunobu reaction with 6-
chloropurine, followed by dihydroxylation, isopropylidenation and deacetylation, 
produced the enantiomeric alcohol, which was oxidized and fluorinated to provide the 
corresponding (+)-enantiomer. Only the ()-enantiomer displayed promising antiviral 
potential against vaccinia and cowpox and human cytomegalovirus.
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Scheme 14  Enantiodivergent routes to 4,4’-difluoro analogue of 5’-noraristeromycin.
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2.4 Azasugars
Polyhydroxylated piperidines (azasugars) containing a nitrogen atom in the place of the 
oxygen atomof the carbohydrate also posses biological activity as glycosidase 
inhibitors.23 Diastereodivergent routes to N-alkylated 1-deoxygalactonojirimycin and 1-
deoxymannojirimycin derivatives have been performed from a protected 1-
deoxynijirimycin intermediate by the Campain and Martin group.24 The stereodivergent 
strategy is based on the Swern oxidation of the free OH groups at C-2 and C-4, followed 
by hydride reduction. Starting from an azasugar the inversion was carried out at C-4 and 
also at C-2 to yield N-nonyl 1-deoxygalactonojirimycin (NN-DGJ) and N-nonyl 1-
deoxymannojirimycin (NN-DMJ), respectively (Scheme 15).
N
OBn
(CH2)8Me
OTBS
HO
BnOi. (ClCO)2, DMSO, Et3N, DCM
-78 ºC to rt
ii. NaBH4, MeOH, 0 ºC to rt
i. NaH, BnBr, TBAI, THF
ii. TBAF, THF
N
OBn
(CH2)8Me
OH
BnO
BnO
70%
N
OBn
(CH2)8Me
OTBS
HO
BnO
77%
i. (ClCO)2, DMSO, Et3N, DCM
-78 ºC to rt
ii. L-Selectride
iii. H2, Pd/C, MeOH, HCl
iv. Dowex 1-X2 (OH- form)
N
OH
(CH2)8Me
HO
HO
OH
64%
NN-DMJ
i. H2, Pd/C, MeOH, HCl
ii. Dowex 1-X2 (OH- form)
N
OH
(CH2)8Me
OH
HO
HO
>99%
NN-DGJ
Scheme 15  Diastereodivergent routes to N-nonyl 1-deoxygalactonojirimycin and 1-
deoxymannojirimycin.
For diastereodivergent routes to D- and L-fagomines, with potent antihyperglycemic 
effect and having potentiation of glucose-induced insulin secretion,25 a 2-chloroamine 
obtained from 3,4,6-tri-O-benzyl-D-glucal has been used as common substrate by Vankar 
and co-workers.26 The main key features of the synthesis is the cyclization step via a SN2 
reaction in the case of L-()-fagomine, whereas in the other case an intramolecular 
reductive amination gave the other D-diastereomer (Scheme 16). Using the same 
divergent routes starting from 3,4,6-tri-O-benzyl-D-galactal, which was transformed into 
the 2-chloro azasugar, the corresponding L-(+)- and D-(+)-1,2-dideoxy-galactostatins 
were synthesized as well.
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BnO
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80% 82%
i. LAH, THF
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BnO
BnO
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OH
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BnO
BnO
NHCbz
90% 95%
i. TFA, DCM
ii. K2CO3, MeCN
PCC, DCM, 4 A MSº
O
OBn
BnO
BnO
NHCbz
N
H
OBn
OBn
OBn
62%
90%
Pd(OH)2, MeOH
H2, 50 psi
10% Pd/C, MeOH
H2, 50 psi
N
H
OH
OH
OH
N
H
OH
OH
OH
80% 80%
L-()-fagomine D-()-fagomine
Scheme 16  Diastereodivergent routes to ()- and (+)-fagomines.
Nishimura and co-workers27 reported a general route to all eight stereoisomeric δ-
glyconic-δ-lactams (glucono-, mannono-, galactono-, talono-, altrono-, idono-, gulono- 
and allono-δ-lactam) from the corresponding γ-lactones for biological evaluation as 
glycosidase inhibitors. The strategy involved diastereodivergent δ-lactam formation with 
configurational retention or inversion at C-4 of a starting δ-lactone. For instance, D-
gulono- and allono-δ-lactams were prepared from L-mannonic acid δ-lactone as shows 
Scheme 17. The starting compound is 2,3:5,6-di-O-isopropylidene-L-mannonic acid γ-
lactone, which was transformed into an azide and used as common intermediate. By 
catalytic reduction with Raney-Ni the lactone was transformed into the protected D-
glucono-δ-lactam, which was deprotected with hydrochloric acid in dioxane to provide 
the expected lactam in good yields. On the other hand, the azide was treated with PPh3 
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and after hydrolysis the protected D-allono-δ-lactam was obtained. Final hydrolysis with 
aqueous HCl gave rise to the expected lactams.
O
H
N
O O
OTr
N3
O
H2, Ra-Ni, MeOH, rt
i. PPh3, MeCN
ii. H2O
HO
OTr
O
O O
H
NHO
OH
O
OH OH
4M HCl, dioxane
H
N
OTr
O
O O
H
N
OH
O
OH OH
4M HCl, dioxane
HO HO
79%
88%
92%
57%
D-gulono--lactam
D-allono--lactam
Scheme 17  Diastereodivergent route to D-gulono- and D-allono-δ-lactams.
A chemical library of 1,2,3-triazolo-carbohydrate mimetics has been prepared by 
Taguchi and co-workers28 starting from D-glucose, D-mannose and D-galactose. The 
diastereodivergent route consisted in a In(OTf)3 catalyzed azidation-1,3-dipolar 
cycloaddition of 1,1-dimethoxyhex-5-yne derivatives with TMSN3 as the key step to form 
4,5,6,7-tetrahydro[1,2,3]triazolo[1,5-a]pyridines. For example, the stereodivergent 
synthesis of triazolo-glucose/idose mimetics is illustrated in Scheme 18. Starting from the 
chiral 2,3,4-tri-O-benzylhex-5-enal, easily prepared from D-glucose, it was transformed 
into the dimethyl acetal and then after catalytic dihydroxylation into a 5,5-
dimethoxypentanal derivative. The homologation under Ohira-Bestmann conditions 
using MeCOC(N2)PO3Me3-K2CO3 gave the key alkyne to perform the azidation-
intermolecular Huisgen reaction providing the corresponding cycloadduct as a mixture of 
α:β  = 1:1.2 epimers. After chromatographic separation and hydrogenolysis the triazole-
glucose mimetics were isolated. For the enantiodivergent synthesis of the triazolo-idose 
mimetic, the starting aldehyde was transformed into the enantiomeric 5,5-
dimethoxypentanal derivative by reduction-silylation-dihydroxylation-acetalyzation-
desilylation. This aldehyde was treated as before to afford the enantiomeric triazolo-idose 
mimetic.
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OBn
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i. NaBH4, MeOH
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HCO
OBn
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OBn
HCO
OBn
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MeCOC(N2)PO3Et2
K2CO3, MeOH
i. HC(OMe)3, PTSA
ii. TBAF, THF
OBn
OBn
OBn
OMe
OMe
OBn
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OHMeO
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98%76%
i. DMP, DCM
ii. MeCOC(N2)PO3Et2 K2CO3, MeOH
TMSN3, In(OTf)3 (5 mol%)
MeOH
N
NN
OMe
OBnBnO
OBn
OBn
OBn
OBn
MeO
OMe
75% ( = 1:1.2) 66%
i. Chromatography
ii. H2, Pd(OH)2/C, MeOH, rt
TMSN3, In(OTf)3 (5 mol%)
DCE, 0 to 80 ºC
N
NN
OMe
OHHO
OH
N
NN
MeO
BnO OBn
OBn
-triazolo-glucose derivative, 96%
-triazolo-glucose derivative, 95%
tri-O-benzyl-trazolo-idose mimic
(78%,  = 1:1.2)
Scheme 18  Enantiodivergent route to triazolo-glucose and idose mimetics.
It can be concluded that stereodivergent routes to carbohydrates are mainly based 
on retention or inversion of the configuration of hydroxyl groups and using carbohydrates 
as starting chiral materials.
3. Amino acids and peptides
3.1 α-Amino acids
Natural and non-natural α-amino acids are an important class of compounds of chemical 
and biological significance and specially to be incorporated into a peptide. Therefore, a 
number of synthetic building blocks and templates, as well as asymmetric catalytic 
methods, have emerged in the last decades.29 Diastereodivergent routes to β-hydroxy-α-
amino acids such as threonine analogues have been described by Misiti and co-workers30 
starting from a 4,5-disubstituted oxazolidine-2-one. A trans-oxazolidin-2-one was the 
common intermediate for the preparation of (2R,3S)- and (2R,3R)-hydroxynorvalines 
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(Scheme 19). For the first amino acid, the oxazolidine-2-one was debenzylated and the 
primary hydroxyl group was oxidized and the acid esterified with diazomethane. Final 
hydrolysis with 6M HCl provided the mentioned α-amino acid. The synthesis of the 
(2R,3R)-diastereomer required an inversion of configuration at C-3. For this purpose the 
starting trans-oxazolidin-2-one was opened with Ba(OH)2 followed by protection of the 
amino group. This Boc-protected β-amino alcohol was treated with the solid complex 
Ph3P·Cl2 to give the cis-oxazolidin-2-one, which was submitted to the same 
transformations than the trans-derivative to provide the anti-β-hydroxynorvaline.
OHN
O
EtBnO
i. Ba(OH)2, H2O, EtOH, reflux
ii. Boc2O, THF
H2, 10% Pd/C, EtOH
OHN
O
EtHO
BnO
NHBoc
OH
97% 71%
OHN
O
EtEtO2C
OHN
O
EtHO
73% 65%
6M HCl
i. Jones ox.
ii. CH2N2, Et2O
iii. 6M HCl
CO2
OH
NH3
_
+
CO2
OH
NH3
_
+
71% 55%
(2R,3S)-3-hydroxynorvaline (2R,3R)-3-hydroxynorvaline
i. Jones ox.
ii. CH2N2, Et2O
i. PPh3·Cl2, CHCl3, 45 ºC
ii. H2, 10% Pd/C, EtOH
Scheme 19  Diastereodivergent routes to (2R,3S)- and (2R,3R)-3-hydroxynorvalines.
Garner’s aldehyde31 and its enantiomer are valuable building blocks for the 
asymmetric synthesis of α-amino acids.32 The Avenoza and Cativiela group33 has used 
the α-methyl derivatives as common starting materials for the diastereodivergent 
synthesis of all isomers of α-methyl-β-phenylserine. To (S)-N-Boc-N,O-isopropylidene- 
α-methyl-β-methylserinal was added phenylmagnesium bromide giving the anti-alcohol 
according to a non-chelating controlled Felkin-Ahn attack (I) on the less hindered face. 
Then cyclization promoted by NaH gave the bicyclic oxazolidine-2-one and, after 
deprotection of the acetonide moiety with the BF3·AcOH complex followed by oxidation 
and acid hydrolysis, afforded (2R,3R)-α-methyl-β-methylserine (Scheme 20). For the 
synthesis of the (2R,3S)-diastereomer the anti-alcohol was treated with triflic anhydride 
to give the bicyclic oxazolidine-2-one with inversion of configuration at the benzylic 
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carbon atom. The same diastereodivergent routes have been carried out with the (R)-N-
Boc-N,O-isopropylidene-α-methylserinal to provide (2S,3S)- and (2S,3R)-α-methyl-β-
phenylserines. The same group has prepared α-methylthreonines by addition of MeMgBr 
Instead of PhMgBr) to the α-methyl Garner’s aldehyde following similar 
diastereodivergent routes.34
NBoc
O
CHO
PhMgBr, THF
-78 ºC NBoc
O
Ph
HO
100%
O
H
N
OtBu
O PhMgBr
NaH
DMF
Tf2O
N
O
O
O
Ph
N
O
O
O
Ph
i. BF3·AcOH
ii. Jones ox.
iii. HCl
iv.
i. BF3·AcOH
ii. Jones ox.
iii. HCl
iv.
HO2C OH
Ph
54%
43%
NH2
HO2C OH
Ph
NH2
I
O
, EtOHO
, EtOH
Scheme 20  Diastereodivergent routes to (2R,3R)- and (2R,3S)-α-methyl-β-phenylserines.
From Garner’s aldehyde, Chattopadhyay and co-workers35 designed a 
diastereodivergent route to epimeric 2-pirrolidinylglycine derivatives, precursors of α,β-
diamino acids. The second stereocenter was stablished by addition of 
trimethylsilylethinyllithium in the absence or presence of ZnBr2 followed by Mitsunobu-
type amination with phthalimide (Scheme 21). Further transformations afforded syn- and 
anti-pyrrolidinylglycine derivatives.
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O
OH
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ii. phthalimide, PPh3, DIAD
PhMe, 0 ºC to rt
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O
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40%
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O
NPhth
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HO2C
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_
Scheme 21  Diastereodivergent routes to syn- and anti-2-pyrrolidinylglycine derivatives.
Diastereodivergent synthesis of α,β-diamino acid building blocks has been carried 
out also from Gardner’s aldehyde by the same group.36 By formation of its imine derived 
from the condensation of the aldehyde with 4-methoxybenzylamine, the in situ allylation 
with allylmagnesium bromide at -30 ºC or with allylzinc bromide at 0 ºC provided the 
corresponding anti- and syn-homoallylic amines, respectively (Scheme 22). These amines 
were converted into different α,β-diamino acids.
NBoc
O CHO 4-MeOC6H4NH2
MgSO4, THF NBoc
O N
PMB
MgBr
ZnBr
-30 ºC NBoc
O
NHPMB
NBoc
O
NHPMB
75%, dr = 7.5/1
74%, dr = 6/1
0 ºC
Scheme 22  Diastereodivergent route to anti- and syn-homoallylamines.
A diastereodivergent route to optically pure syn- and anti-β-substituted serine 
derivatives has been reported by Hruby and co-workers.37 As an example, the common 
intermediate cyclic sulfate -prepared from the corresponding diol resulting by Sharpless 
asymmetric dihydroxylation in the presence of AD-mix-α of the α,β-unsaturated benzyl 
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ester- was transformed into a β-hydroxy α-amino acid. Ring-opening of this sulfate with 
NaN3 with inversion of the configuration at the α-position, and reduction of azido esters 
with PPh3 gave (2S,3S)-β-propyl substituted serine (Scheme 23). On the other hand, the 
sulfate was treated with LiBr and then with NaN3 to give the syn-azido ester, according 
to two inversions of the configuration, which was reacted with PPh3 to the corresponding 
(2R,3S)-β-propyl serine derivative.
The enantiomeric sulfate from AD-mix-β dihydroxylation can be also used for the 
diastereodivergent synthesis of (2R,3R)- and (2S,3R)-β propyl serine derivatives. Starting 
from azido esters, the synthesis of cysteine derivatives was also accomplished.
O
S
O
OO
CO2Bn
OBn
OOH
N3
OBn
OOH
Br
i. NaN3, Me2CO, H2O
ii. 20% H2SO4, Et2O
i. LiBr, THF
ii. 20% H2SO4, Et2O
80% 80%
PPh3, THF, H2O
i. NaN3, DMSO
ii. PPh3, THF, H2O
OBn
OOH
NH2
OBn
OOH
NH2
90% 65%
Scheme 23  Diastereodivergent routes to (2S,3S)- and (2R,3S)-β-propyl serine derivatives.
An enantiodivergent approach to α,α-dialkylated α-amino acids using Curtius 
rearrangement as the key step was reported by Spino and Gobdout.38 The common alcohol 
intermediate was transformed into (S)-α-methylvaline by silylation followed by 
ozonolysis to a chiral acid, which was treated with diphenylphosphoryl azide (DPPA) and 
then submitted to desilylation and oxidation (Scheme 24). In the other route to (R)-α- 
methylvaline, oxidation followed by DPPA treatment and quenching with 9-
fluorenylmethanol provided the protected allylic amine. Subsequent ozonolysis to an 
aldehyde and oxidation with NaClO2 afforded N-Fmoc-protected (R)-α-methylvaline.
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i. TBDPSCl, Im
ii. O3, Jones ox.
i. Jones ox.
ii. DPPA, PhMe, heat
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FmocNH
iPr H
iPr
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ii. HF, Py
iii. Jones ox.
i. O3, Me2S
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63% 55%
Scheme 24  Enantiodivergent routes to (S)- and (R)-α-methylvaline derivatives.
The LFA-1 antagonist BIRT-377 mediates leukocyte adhesion that is implicated 
in a number of immunological processes. Both enantiomers have been prepared using 
Curtius rearrangement as the key step by Back and co-workers.39 Starting from dimethyl 
2-(4-bromobenzyl)-2-methylmalonate the desymmetrization with porcine liver esterase 
(PLE) gave the common intermediate. The amide was prepared by condensation of its 
acyl chloride with 3,5-dichloroaniline and after ester hydrolysis followed by Curtius 
rearrangement using DPPA gave the hydantoin, which by final N-methylation, provided 
the corresponding BIRT-377 was obtained (Scheme 25). Enantiodivergently, its 
enantiomer was prepared by treatment of the starting half ester first with DPPA, giving 
the isocyanate, followed by addition of 3,5-dichloroaniline in the presence of BF3·Et2O 
the hydantoin was formed, which was submitted to final N-methylation in an overall yield 
of 37%.
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Scheme 25  Enantiodivergent routes to BIRT-377 and ent-BIRT-377.
Recently, Liu and co-workers40 have described a temperature-dependent 
enantiodivergent route to (R)- and (S)-α-amino acids by alkylation of a camphor-based 
tricyclic iminolactone. Using LDA as base at low temperature endo-alkylation took place 
giving (S)-AAs after HCl hydrolysis, whereas deprotonation at room temperature, either 
with LDA or KOtBu, afforded exo-products, precursors of (R)-AAs (Scheme 26).
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Scheme 26  Enantiodivergent routes to (S)- and (R)-AAs.
Heterocyclic 3-hydroxypipecolic acids have been synthesized in a 
diastereodivergent manner using a L-serinol derivative as starting material by Jourdant 
and Zhu.41 The common intermediate is a N-Boc disubstituted piperidine, which after 
protection of the secondary alcohol and desilylation, the resulting primary alcohol was 
oxidized and hydrolyzed to afford (2R,3S)-3-hydroxypipecolic acid (Scheme 27). On the 
other hand, the cis-derivative was obtained by Swern oxidation of the secondary alcohol 
and reduction with NaBH4 giving the expected (2R,3S)-3-hydroxypipecolic acid using 
the previously described steps.
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Page 25 of 87 Organic & Biomolecular Chemistry
25
Scheme 27   Diastereodivergent routes to (2R,3R)- and (2R,3S)-3-hydroxypipecolic acid.
La Corre and Dhimane42 have reported diastereodivergent routes to cis- and trans-
5-guanidinopipecolic acids from methyl N-Boc-5,6-dehydropipecolate prepared from 
racemic methyl N-Boc-pipecolate. For the cis-derivative the common intermediate was 
submitted to hydroboration-oxidation with trimethylamine N-oxide (TMO) to provide 
trans-5-hydroxypipecolate, which was mesylated and allowed to react with NaN3 and 
then submitted to hydrogenolysis, to give cis-5-aminopipecolate. By reaction of the 
amino group with N,N-di(benzyloxycarbonyl)-S-methylthiourea the cis-isomer of 
arginine analogue was obtained (Scheme 28). In the other route to the trans-isomer, the 
dehydropipecolate was treated with NaN3 and cerium(IV) ammonium nitrate (CAN) to 
provide, after reduction of the α-amino ether moiety, methyl trans-5-azidopipecolate. 
Hydrogenolysis of the azido group and guanidine formation led to the trans-arginine- 
protected cis-5-guanidinopipecolate.
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ii. TMO·H2O, THF, heat
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Scheme 28  Diastereodivergent routes to methyl cis- and trans-5-guanidinopipecolates.
Enantioenriched 5-aminopipecolic acids have been diastereodivergently prepared 
from commercially available (S)-γ-(hydroxymethyl)butyrolactone by the Contini and 
Occhiato group.43 This lactone was transformed into methyl cis-5-hydroxypipecolate 
which, by functional and protecting group manipulation, provided protected trans-4-
aminopipecolic acid (Scheme 29). For the preparation of the cis-derivative the 
configuration of the hydroxyl group at the 5-position was inverted under Mitsunobu 
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conditions. The cis-isomer was used to construct a cyclic arginine-glycine-aspartic acid-
containing peptidomimetic, which compete with biotinylated vitronectin for binding with 
the isolated αVβ3-integrin (IC50 = 4.2 ± 0.9 nM).
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Scheme 29  Diastereodivergent routes to (1S,5R)- and (1S,5S)-5-aminopipecolic acid 
derivatives.
Kawabata and co-workers44 have reported enantiodivergent routes for the 
intramolecular cyclization of chiral enolates via memory of chirality. In the case of ethyl 
N-3-bromopropyl N-Boc-phenylalaninate the cyclization using KHMDS as base in DMF 
at -60 ºC gave the (S)-prolinate derivative in 94% yield and 98% ee, whereas using lithium 
2,2,6,6-tetramethylpiperidine (LTMP) in THF at 20 ºC the corresponding enantiomer was 
formed in 93% yield and 91% ee (Scheme 30). Other examples with different amino esters 
provided different 4- and 5-membered amino acid derivatives. Alternatively, conjugate 
addition in the cinnamate containing alaninate gave the tetrahydroisoquinoline amino acid 
in enantiodivergent manner.
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Scheme 30  Enantiodivergent routes to heterocyclic amino acids via memory of chirality.
As it was previously described in Scheme 22, the diastereodivergent addition of 
allylmagnesium bromide or allylzinc bromide to an imine gave the corresponding syn- 
and anti-homoallylamines. This strategy has been used by the same authors45 using (R)-
2-cyclohexylideneglyceraldehyde and N-benzylamine derived imine (Scheme 31). The 
corresponding homoallylic amines have been further transformed into methyl (R)- and 
(S)-azetidine-2-carboxylates.
CHO
O
O
BnNH2 MgSO4, 0 ºC to rt
O
O N
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0 ºC to rt
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O
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Scheme 31  Diastereodivergent routes to homoallylamines precursors of methyl (R)- and (S)-
azetidine α-carboxylates.
3.2 β-Amino acids
In the field of β-amino acids, α-hydroxy-β-amino acids have received especial attention 
due to their utility as substrates for the synthesis of a wide variety of peptide isosteres46 
and as constituents of several natural products such as paclitaxel,47 bestatin 
(aminopeptidases inhibitor),48 KRI 1314 (a renin inhibitor),49 microginin (an ACE 
inhibitor)50 and dideoxykanamycin A (an antibacterial agent).51 The Pericás and Riera 
group52 reported diastereodivergent routes to anti- and syn-α-hydroxy-β-amino acids 
from anti-3-amino-1,3-diols. Starting from the monosilylated derivative, by functional 
group transformations, the corresponding methyl N-Boc protected anti-α-hydroxy-β-
amino ester was prepared. On the other hand, by Mitsunobu inversion of the secondary 
hydroxy group the syn-α-hydroxy-β-amino ester was synthesized (Scheme 32).
OTBS
NHBoc
OH
i. 4-O2NC6H4CO2H, PPh3
DEAD, PhH, rt
ii. DIBALH, DCM, -20 ºC
iii. CH2=CHOEt, PPTS, DCM, rt
i. CH2=CHOEt, PPTS, DCM, rt
ii. TBAF, THF
.
OH
NHBoc
O OEt
OTBS
NHBoc
O OEt
67% 42%
i. TBAF, THF
ii. RuCl3, NaIO4, MeCN
H2O, CCl4, NaHCO3
iii. CH2N2, Et2O
i. RuCl3, NaIO4, MeCN
H2O, CCl4, NaHCO3
ii. CH2N2, Et2O
CO2Me
NHBoc
OH
CO2Me
NHBoc
OH
58% 44%
Scheme 32  Diastereodivergent routes to α-hydroxy-β-amino acid methyl esters.
Williams and co-workers53 have described the diastereodivergent synthesis of 
tetrahydro-1,4-oxazinones precursors of enantiomeric isothreonines and nor-C-statines. 
In Scheme 33 the routes for α-hydroxy-β-amino acids, starting from anti-3-
methyloxazinone have been depicted. This compound was transformed into the 
corresponding oxazinone precursor of (2S,3R)-isothreonine by treatment with DIBALH 
and acetylation of the intermediate lactol. The other epimeric oxazinone was prepared by 
enolization followed by reduction and acetylation.
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Scheme 33  Diastereodivergent routes to oxazinones precursors of enantiomeric isothreonines.
Conformationally constrained β-amino acids54 and β-oligomers55 have interesting 
biological properties allowing the production of novel antibiotics and nonhaemolytic 
agents among other pharmaceuticals. Enantiodivergent synthesis of (+)- and ()-2-
aminocyclobutane-1-carboxylic acids has been reported by Ortuño and co-workers.56 
Starting from a chiral half-ester, which results from the enzymatic desymmetrization of 
meso-cyclobutane-1,2-dicarboxylic acid methyl ester, methyl (+)-β-aminocyclobutane-1-
carboxylate was prepared using Curtius rearrangement and protecting group 
transformations (Scheme 34). On the other hand, the ()-enantiomer was synthesized by 
Curtius rearrangement on the carboxylic acid. These β-amino acids have been self-
condensed and coupled with one another to provide bis(cyclobutene)-β-dipeptides.
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Scheme 34  Enantiodivergent routes to Cbz-protected (+)- and ()-β-aminocyclobutanecarboxylic 
acids.
Temperature-dependent diastereodivergent routes to cyclohexane-5-hydroxy-β-
amino esters have been carried out by Fülöp and co-workers.57 As starting compound a 
cyclohexene cis-β-amino acid was used, which was transformed into the common 
intermediate by iodolactonization-deiodination. This lactone was opened with NaOEt at 
0 ºC giving after hydrogenation the (1R*, 2S*,5R*)-5-hydroxy-β-amino ester. However, 
performing the lactone opening at room temperature epimerization of C-1 occurred giving 
the trans-diastereomer (Scheme 35). These 5-hydroxylated-β-amino esters were used for 
the synthesis of exo-methylenic cyclohexane β-amino acid derivatives.
CO2H
NHBoc
O
O
NHBoc
i. NaOEt, EtOH, 0 ºC, 1 h
ii. H2,Pd/C, EtOAc, 0 ºC
ii. H2,Pd/C, EtOAc, 20 ºC
i. NaOEt, EtOH, 20 ºC, 12 h
HO CO2Et
NHBoc
HO CO2Et
NHBoc
62%
59%
Scheme 35  Diastereodivergent routes to cyclohexane 5-hydroxy-β-amino ester derivatives.
Diastereodivergent synthesis of protected β-amino-γ-hydroxy esters from a 
common bicyclic β-lactam has been achieved by Carrera and co-workers.58 Starting from 
benzoic acid and using enzymatic dihydroxylation with the mutant strain Ralstonia 
eutropha B9, an enantiopure cis-cyclohexadiendiol was obtained. This compound was 
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further transformed into the β-lactam, which by treatment with KCN in methanol gave an 
aziridine. Further treatment with NaHSO3 in aqueous acetone gave the protected β-amino-
γ-hydroxy ester (Scheme 36). Treatment with K2CO3 in water at 100 ºC, the starting 
lactam gave a γ-lactone by intramolecular SN2’ attack of the carboxylate on the allyl 
bromide, which was hydrolyzed in situ to the corresponding β-amino acid and after 
esterification with diazomethane to the diastereomeric β-amino -γ-hydroxy methyl ester.
TsN O
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Br
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Ralstonia eutrophia B9
HO2C OH
OH
KCN, MeOH, DMF, rt
K2CO3, KCN (cat)
H2O, DMF, 100 ºC
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O
O
CO2Me
95% O
O
O
OTsNH
HO
O
O
TsNH
CO2K
NaHSO3, Me2CO, H2O, 75 ºC
HO
O
O
TsNH
CO2Me
i. H+
ii. CH2N2, Et2O
HO
O
O
TsNH
CO2Me
90% 82%
Scheme 36  Diastereodivergent routes to β-amino-γ-hydroxy esters.
3.3 γ-Amino acids
Aliphatic γ-amino-β-hydroxy acids are found in a number of natural and synthetic 
compounds with protease inhibitory activity.59 Kim and co-workers60 have studied 
diastereodivergent routes to (3S,4S)- and (3R,4S)-4-amino-3-hydroxy-5-phenylpentanoic 
acid  (AHPPA) from a N-Boc-L-phenylalanine derivative as common precursor.  By 
intramolecular conjugate addition of this product a trans-oxazolidine was formed, which 
after oxidative cleavage and hydrolysis, gave a mixture of syn- and anti-diastereomers 
separable by column chromatography. Final ester hydrolysis provided the N-Boc 
derivative of (3S,4S)-AHPPA (Scheme 37). On the other hand, direct intramolecular 
epoxidation of the starting compound gave opposite configuration of the hydroxy group 
at the 3-position. Therefore, the N-hydroxymethyl group was acetylated and oxidized 
with H2O2 to a N-hydroperoxymethyl group. Without isolation, this hydroperoxide was 
transformed into the corresponding epoxide under basic conditions. Removal of the N-
hydroxymethyl group by PDC oxidation and methanolysis, followed by hydrogenolysis 
of the epoxide, afforded a mixture of anti- and syn-isomers. Subsequent separation by 
column chromatography and ester hydrolysis provided N-Boc protected (3R,4S)-AHPPA.
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Scheme 37  Diastereodivergent routes to (3S,4S)- and (3S,4R)-N-Boc-AHPPAs.
γ-Aminobutiric acid (GABA) and derivatives are inhibitory neurotransmitters of 
the central nervous system (CNS).59a Ortuño and co-workers61 have synthesized ()- and 
(+)-3-amino-2,2-dimethyl-1-carboxylic acids in an enantiodivergent manner starting 
from ()-cis-pinononic acid easily accessible by oxidative cleavage of ()-verbenone. 
This acid was converted into the acyl azide, which was submitted to a Curtius 
rearrangement in the presence of benzyl alcohol to produce the corresponding carbamate. 
Lieben degradation of the methyl ketone with NaOBr followed by methylation with 
diazomethane provided methyl (-3-amino-2,2-dimethylcyclobutane-1-carboxylate 
(Scheme 38). Alternatively, half ester, prepared from ()-cis-pinononic acid,62 was 
submitted to Curtius rearrangement to provide the carbamate precursor of methyl (+)-3-
amino-2,2-dimethylcyclobutane-1-carboxylate. These compounds were incorporated into 
diastereomeric bis(cyclobutane)-γ-dipeptides.
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Scheme 38  Enantiodivergent routes to ()- and (+)-3-amino-2,2-dimethylcyclobutane-1-
carboxylic acid derivatives.
Recently, Jakubec and co-workers63 have reported diastereodivergent routes to 
cyclic analogues of 2,3-cis- and 2,3-trans-γ-aminobutyric acid (GABA). For the 2,3-cis-
substituted GABA analogues, a carbon chain extension of the starting γ-substituted 2-
aminobutanolides64 by a modified Wittig reaction was used, whereas for the trans-isomer 
a Horner-Wadsworth-Emmons (HWE) reaction and an intramolecular oxa-Michael 
addition were the key steps. By reaction of several lactones with Ph3PCHCO2Et followed 
by hydrogenation bicyclic lactams were obtained.64 These lactams were submitted to 
sodium-mediated debenzylation followed by Boc protection providing 2,3-cis-GABA 
analogues (Scheme 39). On the other hand, by DIBALH reduction to lactols followed by 
HWE reaction gave unsaturated esters, which underwent intramolecular 5-exo-trig 
cyclization using TBAF as base. After final debenzylation 2,3-trans-GABA analogues 
were isolated.
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Scheme 39  Diastereodivergent routes to 2,3-cis- and 2,3-trans-substituted GABA analogues. 
3.4 Aminophosphonic acids
α-Aminophosphonic acids are surrogates of α-amino acids where the planar carboxylic 
acid is replaced by a sterically more demanding tetrahedral phosphonic acid. They have 
received especial interest in agrochemistry and in medicinal chemistry.65 
Diastereodivergent routes to racemic octahydroindole-2-phosphonic acids analogues of 
phosphoproline have been prepared by the Ordóñez and Cativiela group66 from 2-
indolinone. This cis-derivative was prepared by hydrogenation of the aromatic ring 
followed by N-Boc protection. Then, DIBALH reduction gave an unstable hemiaminal, 
which was treated in situ with MeOH and catalytic PPTS, to yield a methoxyaminal. After 
treatment with P(OMe)3 in the presence of BF3·Et2O gave, through a N-acyliminium 
intermediate, dimethyl N-Boc-octahydroindole-2-phosphonate with (2S*,3aS*,7aS*) 
stereochemistry. Final treatment with HBr provided the cis-phosphonic acids (Scheme 
40). The synthesis of the epimeric (2R*,3aS*,7aS*)-derivative was carried out by N-Boc 
protection of 2-indolinone and reduction with lithium triethylborohydride (Super-
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Hydride®) to the hemiaminal that, after treatment with BF3·Et2O and P(OMe)3, afforded 
the N-Boc-indoline-2-phosphonate. After hydrogenation of the benzene ring and 
deprotection the corresponding trans-phosphonic acid was obtained.
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Scheme 40  Diastereodivergent routes to cis- and trans-octahydroindole-2-phosphonic acids.
The same group reported diastereodivergent routes to other phosphoproline 
derivatives having an octahydroisoindole instead of an octahydroindole bicyclic system.67 
In this case, N-Boc-isoindolin-1-one was used as common starting compound. By 
hydrogenation of the benzene ring, followed by DIBALH reduction of the carbonyl 
group, the iminium intermediate was treated with P(OMe)3 giving the cis-phosphonate, 
which was deprotected to the cis-aminophosphonic acid (Scheme 41). For the trans-
derivative, N-Boc-isoindolin-1-one, was first prepared and after reduction with DIBALH 
and treatment with BF3·Et2O and P(OMe)3 the corresponding trans-phosphonate was 
obtained. Final hydrogenation and treatment with HBr provided the trans-
aminophosphonic acid.
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Scheme 41 Diastereodivergent routes to (1R*,3aR*,7aS*)- and (1S*,3aR*,7aS*)-
octahydroisoindole-1-phosphonic acids.
Diastereodivergent synthesis of racemic (3-aminocyclopentane)alkylphosphinic 
acids, considered as conformationally  restricted analogues of GABA, has been 
performed by Hanrahan and co-workers.68 For instance, starting from (β-
hydroxycyclopent-1-en)isopropylmethylphosphinate, its silylation followed by 
hydrogenation gave a 9:1 mixture of cis/trans-cyclopentane derivatives. After 
desilylation, the mixture of alcohols was aminated under Mitsunobu conditions to give, 
after HCl hydrolysis and purification by ion exchange chromatography, the 
corresponding trans-(3-aminocyclopentane)methylphosphinic acid (Scheme 42). In the 
other case, the starting material was first aminated under Mitsunobu conditions and then 
N-Boc protected and hydrogenated to provide the saturated cyclopentane derivatives in 
95/5 cis/trans diastereomeric ratio. After final hydrolysis and purification the cis-(3-
aminocyclopentane)methylphosphinic acid was isolated. The same methodology has 
been carried out starting from (3-hydroxycyclopent-1-ene)-n-butylethylphosphinate.
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Scheme 42  Diastereodivergent routes to trans- and cis-(3-
aminocyclopentane)methylphosphonic acids.
4. Alkaloids
4.1 Pyrrolidine derivatives
Naturally occurring 3,4-dihydroxy-2,5-bis(hydroxymethyl)pyrrolidine (DMDP) and its 
analogues are selective inhibitors of glycosidases as polyhydroxylated piperidines.23 
Kumar and Ramesh69 have reported diastereodivergent routes to two diastereomers of 
DMDP from tri-O-benzyl-D-glucal as starting chiral material, which was transformed into 
a common intermediate via cleavage of the O-C-1 bond. This protected β-amido pentaol 
was submitted to cyclization under Mitsunobu conditions and after N-detosylation and 
deacetylation with magnesium, followed by catalytic hydrogenation, provided 
(2S,3R,4R,5S)-DMDP (Scheme 43). Alternatively, the common intermediate was 
oxidized and reduced to its epimer at C-5, which after cyclization under Mitsunobu 
conditions, gave the hydroxylated N-tosylpyrrolidine. Final reductive deprotection as 
above mentioned afforded (2R,3R,4R,5S)-DMDP.
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Scheme 43  Diastereodivergent routes to (2S,3R,4R,5S)- and (2R,3R,4R,5S)-DMDP.
The Martín and Padrón group70 has reported enantiodivergent routes to (+)- and 
()-pyrrolidine 197B alkaloids, which have homolytic and antibiotic activities, from L-
glutamic acid. For the first enantiomer, the common starting aldehyde was submitted to 
Wittig olefination followed by hydrogenation. N-Boc deprotection, DIBALH reduction 
and tosylation provided the corresponding aziridine, which was opened by 
allylmagnesium bromide, and the resulting N-tosylamine was first submitted to an alkene-
metathesis reaction and then to FeCl3-catalyzed intramolecular hydroamination. Final 
desulfonylation71 gave (+)-pyrrolidine 197B (Scheme 44). In the other route, the aldehyde 
was olefinated and then cyclized under FeCl3 catalysis to yield a trans-pyrrolidine 
derivative. This intermediate was reduced with DIBALH to a primary alcohol and 
oxidized to an aldehyde, which was homologated by Wittig olefination and, after further 
hydrogenation, provided after deprotection71 the ()-pyrrolidine 197B.
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Scheme 44  Enantiodivergent routes to (+)- and ()-pyrrolidine 197B alkaloids.
Enantiopure trans-2,5-disubstituted pyrrolidines are constituent units of natural 
pyrrolizidine and indolizidine alkaloids constituents of ant venom and frog poison. 
Lhommet and co-workers72 have synthesized the pyrrolizidine alkaloids (+)- and ()-
xenovenine, found in ant venom (Solenopsis xenovenum), by enantiodivergent routes 
from the same chiral intermediate. The synthesis of (+)-xenovenine began by reduction 
of the tosylate with the superhydride to the trans-pyrrolidine, followed by oxidative 
hydroboration of the allyl substituent and final oxidation and hydrogenation73 (Scheme 
45). In the case of ()-xenovenine, the tosylated alcohol underwent nucleophilic displaced 
with n-hexyl2CuLi and the resulting trans-pyrrolidine was oxidatively hydroborated. The 
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resulting alcohol was oxidized to an aldehyde and by addition of MeMgBr a mixture of 
diastereomeric alcohols was obtained. After oxidation and hydrogenation, the ()-
alkaloid was obtained. 
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Scheme 45  Enantiodivergent routes to (+)- and ()-xenovenine.
Enantiodivergent routes to poison-frog pyrrolizidine alkaloids 251O and trans-
223B have been reported by Toyooka and co-workers74 determining their absolute 
stereochemistry. The pyrrolizidine 251O has been detected in poison-frogs of 
Madagascar and in Malagasy ants. Enantiodivergent routes started from the common 
intermediate lactam,75 which was transformed into the corresponding homoallyl lactam,76 
N-Boc protected and opened with n-propylmagnesium bromide to give a ketone. After 
cyclization and subsequent reduction of the iminium ion with Ph3SiH, the cis-pyrrolidine 
was obtained. Cross-metathesis with ethyl acrylate to yield the ester and subsequent 
cyclization promoted by AlCl3, followed by treatment with K2CO3, afforded the 
pyrrolizidine. Finally, half-reduction of the ester with DIBALH, followed by Wittig 
olefination of the resulting aldehyde and hydrogenation, furnished (+)-251O (Scheme 
46). For the synthesis of its ()-enantiomer, the iodomethyl lactam was alkylated with n-
hexylmagnesium bromide, then Boc-protection and ring opening with 4-
butenylmagnesium bromide afforded a ketone, which was cyclized to the enantiomeric 
lactam. Further transformations as above mentioned provided ent-251O.
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i. DIBALH, DCM, -50 ºC
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iii. H2, 10% Pd/C, EtOAc
+ _
i. DIBALH, DCM, -78 ºC
ii. Ph3Pn-C5H11 Br , nBuLi, THF, 0 ºC to rt
iii. H2, 10% Pd/C, EtOAc
N
H
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H
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46% 50%
(+)-251O ()-251O
MgBr
i. AlCl3, DCM, rt
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+ _
Scheme 46  Enantiodivergent routes to (+)- and (-)-2510 pyrrolizidine alkaloids.
Polyhydroxylated pyrrolizidine alkaloids have emerged as potential therapeutic 
agents due to their bioactivity as inhibitors of glycosyl hydrolases.23,77 Based on a 
transannular iodoamination of substituted 1,2,3,4,7,8-hexahydroazocine scaffolds, 
Davies and co-workers78 developed diastereodivergent routes to the synthesis of ()-
hyacinthacine A1 and ()-7a-epi-hyacinthacine A1. The common eight membered 
starting compound was transformed into ()-hyacinthacine A1 by deprotection with HCl, 
followed by diastereoselective iodoamination and hydrogenolysis (Scheme 47). On the 
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other hand, performing firstly the diastereoselective hydroamination and then 
hydrogenolysis provided ()-7a-epi-hyacinthacine A1. The different stereochemical 
outcome during the intramolecular iodoamination can be explained by the reversible 
iodonium conformation in intermediates I and II.
N
O O
PMP
OHi. 3M HCl, MeOH, heat
ii. I2, MeOH
I2, NaHCO3, DCM, rt
N
H
OH
OHI
H OH
N
HI
H OH
+ +
O
O
I
_
I
_
69% >99%
i. H2, Pd/C, Et3N, MeOH, rt
ii. 6M HCl, MeOH
N
H OH
OH
OH
75%
N
H OH
OH
OH
94%
()-7a-epi-hyacinthacine A1()-hyacinthacine A1
NH
HO OH
OH
I
+ N
O O
OH
I
+ PMP
I
II
H2, Pd/C, Et3N, MeOH, rt
Scheme 47  Diastereodivergent routes to ()-hyacintacine A1 and ()-7a-epi-hyacintacine A1 and 
proposed intermediates I and II.
The Minehira, Kato and Toyooka group79 described enantiodivergent routes to 
related hyacinthacine alcaloids with structures I and ent-I from the chiral N-Boc-cis-2,5-
dihydroxymethyl monoacetate II80 (Scheme 48). 
N
OH
H
OH
HO
R
or N
OH
H
OH
HO
R
N
HO
Boc
OAc
[R = H, OH, Et, nBu]I IIent-I
Scheme 48  Enantiomeric trihydroxylated pyrrolizidines.
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Diastereodivergent routes to 7-hydroxypyrrolizidine alkaloids such as casuarina 
and 7-epi-australina have been reported by Reiβig and Goti groups81 from a bicyclic 1,2-
oxazine derivative, prepared by reaction of lithiated 1-benzyloxyallene with a 
carbohydrate-derived nitrone.82 Quantitative hydroboration-oxidation of this oxazinone 
by the Si-face, followed by reductive ring opening with Zn or SmI2 and dimesylation of 
the diol unit, gave the intramolecular SN2 yielding the corresponding pyrrolizidine. 
Reductive deoxygenation of the mesylate with DIBALH and final debenzylation with 
hydrogen gave 7-epi-australine (Scheme 49). When the same oxazinone was first 
subjected to a chemoselective reduction of the N-O bond with the [Mo(CO)6]/NaBH4 
combination or SmI2 the pyrrolidine derivative was obtained. After mesylation, a ring 
closing took place providing a pyrrolizidine, which after hydrogenation gave a mixture 
of australine and its 7-oxo derivative. This mixture was treated with NaBH4 to provide 
australine in 59% overall yield.
O
N
BnO
H OBn
OBn
OBn
i. BH3·THF, THF, rt
ii. H2O2, NaOH
SmI2, THF, rt
O
N
BnO
H OBn
OBn
OBn
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BnO
H OBn
OBn
OBn
HO
HO
100% 68%
SmI2, THF, rt MsCl, Et3N, DCM, rt
HN
BnO
H OBn
OBn
OBn
HO
HO
100%
N
OBn
OBn
OBn
HBnO
100%
MsCl, Et3N, DCM, rt H2,10% Pd/C, MeOH, HCl
N
OBn
OBn
OBn
HBnO
MsO
N
OH
OH
OH
HHO
+
N
OH
OH
OH
HO
87%
NaBH4, MeOH, rt100%
100%
i. DIBALH, PhMe, heat
ii. H2,10% Pd/C, MeOH, HCl
australine
N
OH
OH
OH
HHO
52%
7-epi-australine
Scheme 49  Diastereodivergent routes to 7-epi-australine and australine.
4.2. Piperidine derivatives 
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The piperidine moiety is present in many natural alkaloids and other biologically active 
compounds, and also in compounds such as hydrogenated quinolines, iosquinolines, 
indolizidines and quinolizidines derivatives.23,83 Amat and co-workers84 described 
enantiodivergent routes to 2-arylpiperidines from a bicyclic lactam derived from (R)-
phenylglycinol. The key step is the reductive deoxygenation with Red-Al or with 9-BBN, 
which took place with retention or inversion of the configuration, respectively (Scheme 
50). Final hydrogenolysis afforded (S)- or (R)-2-phenylpiperidine, respectively. To 
explain the observed stereochemistry, intermediates I and II were proposed. In 
intermediate I, after complexation with Red-Al, hydride delivering took place by the same 
face than the C-O bond. However, using 9-BBN an ion paired intermediate II was formed 
followed by intramolecular hydride delivery from the preferred conformation. The same 
methodology allowed diastereodivergent routes to cis- and trans-3-ethyl-2-
phenylpiperidine. In addition, a concise route to the tobacco alkaloid (S)-2-(3-
pyridyl)piperidine ()-anabasine was also reported.
N OO
Ph
Ph
Red-Al, THF
heat
9-BBN, THF
heat
N
OH
Ph
Ph
N
OH
Ph
Ph
54%, dr = 98:2
75%,dr = 97:3
H2,10% Pd/C, MeOH, rt
H2,10% Pd/C, MeOH, rt
H
N Ph
H
N Ph
70%
70%
N
O
Ph
H
Ph
H
Al
_
N
O
B
HPh
Ph+
_
I II
Scheme 50  Enantiodivergent route to (S)- and (R)-2-phenylpiperidine.
The same group reported diastereodivergent routes to enantiopure ethyl cis- and 
trans-3-ethylpiperidineacetates.85 The key step is the conjugate addition of an enolate or 
a cuprate to unsaturated bicyclic lactams. Starting from the saturated bicyclic lactam, after 
treatment with KH and methyl phenylsulfinate, followed by heating of the resulting 
sulfoxides, the corresponding unsaturated lactam was obtained (Scheme 51). The 
conjugate addition of the enolate of ethyl 1,3-dithiolane-2-carboxylate took place with 
high diastereoselectivity under thermodynamic control and, after desulfuration, the 
corresponding ester was obtained. Subsequent reduction of the carbonyl group with 
borane and reductive cleavage of the oxaziridine ring gave, after debenzylation, trans-3-
ethyl-4-piperidineacetate derivative. Alternatively, hydrogenolysis of the C-N bond with 
calcium in liquid NH3 and treatment with Et3SiH in TFA afforded the trans-lactam. For 
the cis-series, the starting bicyclic lactam was transformed into the unsaturated lactam85b 
which, after conjugated addition of lithium allylcuprate under kinetic control, gave a 
Page 45 of 87 Organic & Biomolecular Chemistry
45
83:17 mixture of diastereomers. The allyl substituent was transformed into the acetate by 
ozonolysis followed by oxidation of the resulting aldehyde and esterification. Following 
the above-mentioned functional group transformations, the cis-series were obtained.
N OO
Ph
Et
i. KH, PhSO2Me, THF, heat
ii. Na2CO3, PhMe, heat
ref 85b
N OO
Ph
Et
N OO
Ph
EtBnO2C
81%
S S
CO2Et
, LDA, THF
Ph3(CH2=CHCH2)Sn, PhLi
CuI, TMSCl, LiCl, THF
N OO
Ph
Et
EtO2C
52% 86%
N OO
Ph
EtBnO2C
i. O3, DCM, MeOH, Me2S
ii. PDC, DMF
iii. TMSCl, EtOH
iv. H2, 10% Pd/C, then PhMe, heat
NiCl2·6H2O, NaBH4, THF, MeOH
N OO
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CO2Et
N OO
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Et
CO2Et
66% 82%
i. BH3·THF
ii. H2, Pd/C, MeOH
i. Ca, NH3
ii. Et3SiH, TFA
H
N
Et
CO2Et
O
H
N
Et
CO2Et
i. Ca, NH3
ii. Et3SiH, TFA
i. BH3·THF
ii. H2, Pd/C, MeOH
H
N
Et
CO2Et
O
H
N
Et
CO2Et
53% 45% 35% 46%
Scheme 51  Diastereodivergent routes to substituted cis- and trans-lactams and piperidines.
Diastereodivergent routes to 2,3,6-trisubstituted piperidines have been reported by 
Liebeskind and co-workers86 from (±)-Tp(CO)2(η3)-pyridinylmolybdenum complexes. 
Depending on the demetalation protocol 2,6-cis-3-trans- or 2,3,6-cis-systems were 
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obtained. The preparation of pyridinyl molybdenum scaffolds with 
hydridotrispyrazolylborate (Tp) as ligand were previously described by the same group.87 
Demetalation using NOPF4 and then addition of the hydride from NaCNBH3 on the 
resulting cationic intermediate delivered the 2,6-cis-3-trans-dehydropiperidines. On the 
other hand, protodemetalation under acidic conditions placed hydrogen at the more 
substituted end of the η3-allylmolibdenum and syn to the TpMo unit giving cis-2,3,6-
trisubstituted dehydropiperidines (Scheme 52). This methodology has been applied to the 
synthesis of indolizidines (±)-209I and (±)-8-epi-209F, as well as ()-indolizidine 251AA 
and ()-dehydroindolizidine 233E.
N
R1
PG
R2 (CH2)3OBn
TpMo(CO)2
i. NOPF6
ii. NaCNBH3
HCl, H2O, MeCN
N
R1
(CH2)3OBn
PG
R2
N
R1
(CH2)3OBn
PG
R2
53-61%
62-66%
R1 = Et, nBu
R2 = n-Pent,
PG = Cbz, (S)-CO2CH(nPr)Ph
O
O
Scheme 52  Diastereodivergent routes to 2,6-cis-3-trans- and cis-2,3,6-trisubstituted 
dehydropiperidines.
A bicyclic piperidine epoxide intermediate has been used by Park and co-workers88 
for the diastereodivergent synthesis of hydroxylated piperidines. By treatment of this 
intermediate with KOH a trans-diaxial ring opening (I; Furst-Partner control89) took place 
giving after N-Boc deprotection with HCl, ent-1,6-dideoxynojirimycin (dDNJ) (Scheme 
53). Alternatively, treatment with H2SO4 provided 5-amino-1,5,6-trideoxyaltrose.
N
Boc
HO
O
i. KOH, dioxane, H2O
ii. HCl, MeOH
H2SO4, dioxane, H2O
N
H
HO
OH
OH
N
H
HO
OH
OH
85%
ent-1,6-dDNJ, 83%
OHN OBoc
I
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Scheme 53  Diastereodivergent routes to ent-1,6-didehydrodeoxynojirimycin and its 
diastereomer.
The dendrobate alkaloid 241D and its 4-oxo derivative are potent inhibitors of 
histrionicotoxin binding to the nicotine receptor as well as the noncompetitive blocker of 
acetylcholine to nicotinic receptor channel complex. Saha and Chattopadhyay90 have 
performed enantiodivergent routes to (+)- and ()-241D. These compounds are a subclass 
of cis-2,6-disubstituted piperidines, which are ubiquitous in the plant and animal 
kingdom. The common oxazabicycle starting compound has been prepared from (R)-2,3-
O-cyclohexylideneglyceraldehyde. For the synthesis of ()-241D, the aldehyde 
functionality was reduced to an alcohol, which after mesylation and reductive removal, 
provided the corresponding methyl-substituted oxazacycle in 65% overall yield. Then, 
the dioxolane moiety was transformed into a nonyl chain through acid-mediated 
deprotection to the diol, oxidative cleavage to the corresponding aldehyde and Wittig 
olefination to the (Z)-alkene. Hydrogenation of the C=C bond and final reductive 
cleavage of the N-O bond provided (D (Scheme 54). By reversal synthetic 
manipulation through the conversion of the aldehyde to a nonyl chain and the dioxolane 
moiety to a methyl group the (+-enantiomer was prepared.
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Scheme 54  Enantiodivergent routes to ()- and (+)-241D alkaloids.
Koskinen and co-workers91 have reported diastereodivergent routes to cis- and 
trans-2-substituted 3-piperidinols. The core motif of numerous bioactive compounds such 
as the selective nonpeptic human neurokinin-1 substance P receptor antagonists L-
733,060 and CP-99,994, the natural products febrifugine (antimalarial) and halofuginone 
(antiprotozoal), was designed. The common starting materials, hydroxyketones, were 
prepared from α-amino acids. In Scheme 55, the synthesis of cis-and trans-2-methyl-3-
hydroxypiperidinols has been depicted. Reduction of the keto group with L-Selectride 
and subsequent Cbz-deprotection by catalytic hydrogenation, gave a diol, which was 
submitted to a modified Apel cyclization92 (PPh3/I2) using P(OEt)3 delivering the cis-N-
benzylpiperidinol. On the other hand, for the trans-piperidinol the hydroxy ketone was 
mesylated and, after Cbz-deprotection and liberation of the free amine with DBU, the 
ketone was reduced with L-Selectride and final Et3N-induced cyclization providing the 
desired diastereomer. Following the methodology described for the cis-isomer, L-
33,060·HCl was also prepared. 
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Scheme 55  Diastereodivergent routes to cis- and trans-3-hydroxy-2-methylpiperidinols.
A particular subclass within the family of piperidines contains a 2-oxygenated side 
chain, such as sedamine, halosaline, 8-epi-halosaline, pelletierine, lobeline, 
andrachcinidine and porantheridine. The Vincent and Kouklovsky group93 has reported 
diastereodivergent routes to access racemic bicyclic isoxazolidine precursors of 2,6-
disubstituted piperidines from a N-alkoxy benzylic lactam. This lactam was reduced with 
DIBALH and then allylmagnesium bromide was added to the resulting iminium cation I 
to furnish the 2,6-trans-disubstituted piperidine after N-O cleavage (Scheme 56). The 
addition of allylmagnesium bromide and then reduction with NaBH3CN (through 
intermediate II) provided the 2,6-cis-disubstituted piperidine after Zn-reduction and N-
Cbz protection. The trans-piperidine has been used for the formal synthesis of 
porantheridine.94 The cis-2,6-disubstituted piperidine is a precursor of andrachcinidine.
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Scheme 56  Diastereodivergent routes to trans- and cis-2,6-disubstituted piperidines.
Natural polyhydroxylated indolizidine alkaloids are not only α- and β-glucosidase 
inhibitors, but also, they showed antiviral activity.23,83 The Cordero and Brandi group95 
has performed the enantiodivergent synthesis of enantiopure trihydroxyindolizidines 
from the cycloadduct of a cyclic nitrone with styrene, ethyl acrylate and fumaronitrile. 
For the synthesis of (+)-trihydroxyindolizidine, the bicyclic isoxazolidines were acylated 
with PMB-protected (E)-5-hydroxy-2-pentenoic acid. The resulting ester underwent the 
domino retro-cycloaddition/intramolecular cycloaddition in refluxing o-dichlorobenzene 
through transition state I. Deprotection with DDQ afforded an alcohol, which after 
mesylation was hydrogenated to give a tricyclic indolizidine through a domino 
isoxazolidine ring opening/intramolecular nucleophilic substitution. Final reduction of 
the lactone moiety afforded the (+)-trihydroxyindolizidine (Scheme 57). In the case of 
using Mitsunobu conditions for the esterification step of bicyclic oxazolidine alcohol with 
(E)-O-PMB-5-hydroxy-2-pentenoic acid, inversion of the configuration at C-4 took 
place. After performing the retro-cycloaddition/intramolecular cycloaddition and 
deprotection of the PMB ether with TFA, the same steps mentioned above furnished the 
()-trihydroxyindolizidine.
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Scheme 57  Enantiodivergent routes to (+)- and ()-trihydroxyindolizidines.  
Diastereodivergent routes to castanospermine and 1-epi-castanospermine have 
been achieved by Huang and co-workers96 from a common chiral building block, that 
means, a tetramic acid derivative. This compound was regioselectively reduced with 
NaBH4 giving a 7:1 mixture of diastereomeric alcohols. The primary alcohol was 
obtained by debenzylation with iodine in refluxing methanol and the resulting triol was 
triacetylated. Deprotection of the lactam with CAN and reduction with borane afforded a 
pyrrolidine, which was cyclized and then debenzylated to castanospermine (Scheme 58). 
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The inversion of the configuration during the reduction of the ketone in the starting 
tetramic acid derivative was achieved in the presence of AcOH at -10 to 5 ºC. After 
benzylation of the diol and debenzylation of the primary alcohol it was tosylated, and the 
lactam deprotected. Cyclization took place after NH deprotection of the lactam with n-
BuLi followed by reduction of the carbonyl group and debenzylation with a 10% Pd/C-
catalyzed transfer hydrogenation to provide 1-epi-castanospermine.
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Scheme 58  Diastereodivergent routes to (+)-castanospermine and 1-epi-castanospermine.
Quinolizidine alkaloids are present mainly in plants and in amphibians, and display 
a broad range of biological activities.23,83 Lasubines I and II are two quinolizidine 
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alkaloids isolated from plants of the Lythraceae family, which have been prepared by 
Carretero and co-workers97 using diastereodivergent routes. The key common 
intermediate is a chiral dihydropyridone obtained by a Cu-catalyzed asymmetric aza-
Diels-Alder reaction of Danishefsky’s diene with a N-tosyl aldimine. Conjugate addition 
of the cuprate derived from 4-chloro-n-butylmagnesium under Comins conditions98 
(CuBr·SMe2/BF3·Et2O) to N-Boc dihydropyridone provided mainly the cis-2,6-
disubstituted piperidone with 9:1 dr. Boc deprotection using SnCl4 and cyclization under 
basic conditions gave the quinolizidine ketone, which was reduced with L-Selectride to 
yield (+)-lasubine II (Scheme 59). For the synthesis of (+)-lasubine I, the starting 
dihydropyridone was N-alkylated with 4-chloro-1-iodo-n-butane and then treated with 
NaI to prepare the corresponding iodo derivative able to be subjected to radical 
cyclization giving mainly the trans-quinolizidinone, which was reduced to the expected 
(+)-lausabine I. 
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Scheme 59  Diastereodivergent routes to (+)-lasubine II and I.
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Kim and co-workers99 have reported diastereodivergent routes to 1-
hydroxyquinolizidinone isomers precursors of natural quinolizidines ()-
homopumiliotoxin 223G and epiquinamides.100,101 The key step is the sequential 
cyclization of the common precursor, a chiral hydroxy lactone prepared through Sharpless 
asymmetric dihydroxylation and subsequent lactonization of ethyl (E)-9-bromonon-4-
enoate. Cyclization of this lactone by means of a Staudinger reaction using DIPEA as 
base in MeOH provided (+)-1-hydroxyquinolizidinone, precursor (+)-epiquinamide101 
isolated from poison frog Epipedobates tricolor (Scheme 60). For the other (-isomer 
the cyclization was performed in acetonitrile instead of methanol. This ()-1-
hydroxyquinolizidinone has been used for the synthesis of ()-epiquinamide101 and ()-
homopumiliotoxin 223,100 which was isolated from the poison of Dendrobates pumilio. 
The authors explain that in the first case the presence of enough water in the solvent favors 
that the nucleophilic MeOH would induce the formation of the epoxide, which gave the 
piperidine and then the lactam through intermediates I and II. However, with the less 
nucleophilic solvent the amino group would lead to the intramolecular SN2 process to 
form the piperidine ring (intermediate III) and then the addition of the solvent would 
force the lactone opening and subsequent cyclization through III. 
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Scheme 60  Diastereodivergent routes to (+)- and ()-1-hydroxyquinolizidiones.
The coryantheine and ipecac alkaloid families contain a wide number of naturally 
occurring compounds with a quinolizidine structural motif. They are mainly isolated from 
the leaves of Uncaria tormentosa (cat claw) and the roots of Cephaelis ipecacuanha 
(Rubiaceae) with a long history of usage as herbal drugs. Diastereodivergent routes to 
()-(15S)-hydroxydihydrocorynantheol, alkaloid isolated from an endemic tree of Puerto 
Rico (Antirhea portoricensis, Rubiaceae), and its (15R)-epimer have been reported by 
Franzén and co-workers.102 The common lactol intermediate was prepared by an one-pot 
process using (E)-5-hydroxypent-2-enal and a β-keto amide using (R)-O-
(trimethylsilyl)diphenylprolinol as organocatalyst as key step for the construction of the 
quinolizidine carbon skeleton. This lactol was used as crude product and was reduced 
with NaBH4 giving a 81:19 mixture of diols, which was characterized as the nonnatural 
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()-(15R)-hydroxydihydrocorynantheol in 57% overall yield (Scheme 61). However, the 
opening of the lactol by acetylation gave a ketone, which was reduced with L-Selectride 
giving the natural ()-(15S)-hydroxydihydrocorynantheol with 77:23 diastereomer ratio 
and in 50% combined overall yield, from the β-keto amide.
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H H
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H H
HO HO
N
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H
H H
HO
88%, dr = 81:19 89%, dr = 77:23
()-(15R)-hydroxydihydrocorynantheol ()-(15S)-hydroxydihydrocorynantheol
Scheme 61  Diastereodivergent routes to ()-(15R)- and ()-(15S)-hydroxydihydrocorynantheol.
Decahydroxyquinolines and mainly 2,5-disubstituted derivatives are constituents of 
poison frog alkaloids.23,83 The Toyooka and Nemoto group103 has performed 
diastereodivergent routes to cis- and trans-fused 2,5-disubstituted octahydroquinoline 
ring systems. As common starting material an enamino ester104 was used. For the cis-
fused decahydroquinoline, the primary alcohol was disilylated and cyclized to afford the 
fused oxazolidinone. After conjugate addition of vinyllithium cuprate, the ester 
functionality was homologated by an Arndt-Eistert reaction. By transformation of the 
ester into the Weinreb amide the corresponding methyl ketone was obtained. The vinyl 
substituent was transformed into a formyl group and then an intramolecular aldol reaction 
provided the cyclic enone, which by conjugate addition of methyllithium cuprate 
furnished the cis-fused decahydroquinoline (Scheme 62). For the trans-isomer conjugate 
addition of vinyllithium cuprate was followed by ester homologation and then formation 
of the oxazolidinone. The ester group was reduced and submitted to Swern oxidation, 
addition of vinylmagnesium bromide to the resulting aldehyde and PCC oxidation to 
afford a vinyl ketone. After a ring-closing metathesis reaction using Grubbs I catalyst and 
conjugate addition of methylmagnesium cuprate the corresponding trans-fused 
decahydroquinoline was obtained.
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Scheme 62  Diastereodivergent routes to cis- and trans-fused decahydroquinolines.
The Amat and Bosch group105 has used 8-allyl substituted oxazolopiperidone 
lactam,106 prepared from (R)-phenylglycinol and δ-oxo esters, as common starting 
material for the synthesis of cis- and trans-hexahydroquinolones. By means of 
allyltrimethylsilane in the presence of TiCl4 the cis-derivative was the major isolated 
product according to intermediate I, which after ring closing metathesis and final removal 
of the phenylethanol moiety with sodium in liquid ammonia provided enantiopure cis-
hexahydroquinolone (Scheme 63). The stereoselectivity of the α-amidoalkylation was 
reversed using allylmagnesium bromide by participation of intermediate II, to give the 
trans-diallylated product, which was further transformed as above into the trans-
hexahydroquinolone.
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Scheme 63  Diastereodivergent routes to cis- and trans-hexahydroquinolines.
The same group107 has prepared 2,5-disubstituted cis-decahydroquinolines 
including ()-pumiliotoxin C (cis-195A) and ()-ent-2-epi-cis-195A from a tricyclic 
hydroquinoline lactam as common starting material. This lactam was prepared from a 
diketo diester and (R)-phenylglycinol. For the preparation of ()-pumiliotoxin C the 
starting lactam was hydrogenated and then converted into the thioamide with Lawesson’s 
reagent. By means of Eschenmoser sulfide contraction conditions, the β-enamino ester 
was obtained. Subsequent hydrogenation gave the desired cis-junction in the 
decahydroquinoline unit by cleavage of the C-O bond, and the saturation of the 
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unsaturated ester. Further functional group transformations provided (-pumiliotoxin C 
hydrochloride (Scheme 64). Unexpectedly, reversing the order of the two first steps gave 
the corresponding epimer, which was further transformed as above into ent-2-epi-cis-
195A.
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Scheme 64  Diastereodivergent routes to ()-pumiliotoxin C and ent-2-epi-cis-195A.
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Diastereodivergent routes to enantiopure cis- and trans-fused trifluoromethylated 
octahydroisoquinolines have been reported by Chen and co-workers.108 The starting 
cyclohexene was obtained by a Diels-Alder reaction of (E)-1,1,1-trifluoro-4-phenylbut-
3-en-2-one with 4-phenylhexa-2,4-dienal organocatalyzed by a chiral protected (4R)-
aminodiarylprolinol. Unexpectedly, the reductive amination step took place in a 
diastereodivergent manner giving cis-fused octahydroisoquinoline using NaBH(OAc)3 
(Scheme 65). However, when NaBH3CN was employed in this reductive amination step 
the epimerization at the α-carbon was not observed and the trans-isomer was obtained in 
78% yield and 95% ee.
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66%, dr = 9:1, ee = 99%
78%, dr > 19:1, ee = 95%
Scheme 65  Diastereodivergent routes to cis- and trans-fused trifluoromethylated 
octahydroisoquinolines.
4.3. Other alkaloids 
Formal total synthesis of both enantiomers of balanol, a fungal metabolite inhibitor of 
protein kinase C, has been carried out by Hudlicky and co-workers109 from 1-bromo-2,3-
dihydroxycyclohexa-4,6-diene obtained by the whole cell fermentation of bromobenzene 
with the recombinant strain Escherichia coli JM109 (pDTG 01).110 The key 
diastereodivergent step is the preparation of the corresponding vinylaziridines. The all-
cis-isomer was obtained by reaction of the common intermediate, the acetonide of the 
diol, with N-bromoacetamide (NBA) in the presence of SnBr4 followed by a KHMDS-
mediated elimination (Scheme 66). This aziridine was transformed into a 4:1 mixture of 
trans- and cis-acetates, which were separated by column chromatography to give, after 
hydrogenation, the fully saturated compound. After transformation into the 
oxazolidinone, it was benzoylated and the acetonide hydrolyzed and then submitted to 
oxidative cleavage to provide a dialdehyde. Final reductive amination with benzylamine 
and hydrogenolysis of the oxazolidinone furnished ()-balanol, a hexahydroazepine 
derivative. For the synthesis of the enantiomeric form, the anti-disposed aziridine was 
obtained by aziridination of the dienediol with PhI=NTs. After ring opening with KOH 
in DMSO and hydrogenation the corresponding protected trans-amino alcohol was 
obtained. Then, the oxazolidinone was prepared using triphosgene and the tosyl group 
was removed with sodium naphthalenide to provide after acylation and hydrogenolysis 
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of the acetonide diol. Following the same transformations than before (+)-balanol was 
obtained in 40% overall yield from 2-(N-tosylamino)cyclohexanol.
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Scheme 66  Enantiodivergent routes to ()- and (+)-balanol. 
The natural occurrence of both enantiomers appears in the group of vinca alcaloids, 
which contain an indole unit. Winterfield and co-workers111 described enantiodivergent 
routes to both vincamine enantiomers from a tetracyclic lactam, prepared by reaction of 
tryptamine with a cyclopropanecarboxaldehyde. Treatment with methyl cyanoacetate 
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followed by opening of this γ-lactam, subsequent rotation with formal inversion at C-16 
and final cyclization provided a new lactam, which was further transformed into (+)-
eburnamonine,112 precursor of (+)-vincamine (Scheme 67). By nucleophilic ring opining 
with KCN isomerization at C-3 took place on the acid-catalyzed cyclization to form an 
acyl indole, which was further transformed into ()-eburnamonine,113 used in the 
synthesis of ()-vincamine.
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Scheme 67  Enantiodivergent routes to (+)- and ()-vincamine.
A phenylglycinol-derived lactam has been used for the diastereodivergent synthesis 
of cis- and trans-2-[(3-ethyl-4-piperidyl)methyl]indole, a key intermediate in the 
synthesis of tetracyclic alkaloids,83 by the Amat and Bosch group.114 The crucial step was 
the conjugate addition of lithiated 2-(2-indolyl)-1,3-dithiane to an unsaturated lactam. 
Under kinetic control the cis-isomer was obtained in 4:1 diastereomeric ratio, while under 
thermodynamic control the enantiopure trans-isomer was only formed (Scheme 68).
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Scheme 68  Diastereodivergent route to cis- and trans-(piperidylmethyl)indoles. 
Chaetominine-type alkaloids are mainly isolated from endophitic fungi. Huang and 
co-workers115 have reported diastereodivergent routes to ()-14-epi-isochaetominine C, 
the enantiomer of the (+)-natural product, and ()-2,3,14-tri-epi-isochaetominine C, 
starting from Ltryptophan. As common starting material, a dihydroindole was used. By 
treatment with NaOMe a bis-epimerization at C-11 and C-14 occurred giving after 
lactamization ()-14-epi-isochaetomicine C (Scheme 69). On the other hand, 
debenzylation of the starting compound followed by cyclization led to 2,3-tri-epi-
isochaetominine C.
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Page 64 of 87Organic & Biomolecular Chemistry
64
Scheme 69  Diastereodivergent routes to ()-isochaetominine isomers.
 
Rapoport and co-workers116 performed the enantiodivergent synthesis of natural 
(+)-anatoxine and its enantiomer from L-glutamic acid. The natural alkaloid is a strong 
nerve-dipolarizing agent isolated from strains of the freshwater blue-green alga Anabaena 
flos-aquae de Breb. A homotropane was used as common starting material, which was 
transformed into a mixture of ketones by ozonolysis of its silyl enol ether. The keto group 
was protected as thioacetal and a Boc-deprotection was performed. Reprotection with 
Boc2O followed by hydrogenolysis of the thioacetal gave the 2-deoxo compound. 
Conversion of the ester group into a methyl ketone and final selenenylation/oxidation117 
and N-protection provided (+)-anatoxin in 18% overall yield (Scheme 70). The unnatural 
enantiomer was prepared from the same intermediate, which was hydrolyzed to the 
corresponding acid and then transformed into its acyl chloride. Treatment with 1-
hydroxy-2 (1H)-piperidinethione gave the O-acyl thiohydroximate, which was treated 
with thiophenol to afford the decarboxylated homotropane. After the same 
selenenynation/oxidation117 and N-Boc deprotection ()-anatoxin was obtained in 30% 
overall yield. 
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Scheme  70  Enantiodivergent routes to (+)- and ()-anatoxin.
Hudlicky and co-workers118 have performed the enantiodivergent synthesis of (+)- 
and ()-codeine using a dienediol, obtained via enzymatic dihydroxylation of β-
bromoethylbenzene with the recombinant strain Escherichia coli JM109 (pDTG 601) that 
over-expresses toluene dioxygenase. The key intermediate is an amino diol, which was 
monosilylated and the free hydroxy group was submitted to Mitsunobu conditions using 
bromoisovanillin as nucleophile. Further Heck reaction followed by a Wittig reaction and 
a second Heck cyclization gave the tetracyclic intermediate. The stereochemistry of C-6 
was adjusted by desilylation, IBX oxidation and reduction to the allyl alcohol, which was 
deprotected with TFA. Final aminomercuration, followed by reduction with LAH, gave 
ent-codeine in a total number of 14 steps from β-bromoethylbenzene (Scheme 71). For 
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the natural enantiomer, Mitsunobu reaction with 4-nitrobenzoic acid and tosylation of the 
other hydroxy group, and then the sequence mentioned above, provided ()-codeine.
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Scheme 71  Enantiodivergent routes to (+)- and ()-codeine.
Diastereodivergent routes to all four stereoisomers of galanthamine have been 
described by Prabahar and co-workers.119 The naturally occurring ()-galanthamine has 
been approved for the treatment of mild to moderate Alzheimer’s disease. Starting from 
()-narwedine, obtained by kinetic dynamic resolution of the corresponding racemate, the 
reduction with L-Selectride occurred through equatorial hydride attack. Then, after 
treatment with HBr, ()-galanthamine hydrobromide was finally isolated (Scheme 72). 
However, using NaBH4/CeCl3 (Luche conditions) an axial hydride attack was 
predominantly observed to afford ()-epigalanthamine. By using the same methodology 
with (+)-narwedine, (+)-galanthamine was obtained.
O
O
MeO
NMe
()-narwedine
NaBH4/CeCl3, DCM/MeOH (1:1)
-55 to 50 ºC
i. L-Selectride, THF, -50 to 45 ºC
ii. HBr, H2O
OH
O
MeO
NMe
OH
O
MeO
NMe
68%
()-epi-galanthamine
()-galanthamine·HBr
85%
+
Br
_
Scheme 72  Diastereodivergent routes to ()-galanthamine and ()-epigalanthamine.
5. Terpenes
Nowadays terpenes play only a minor role as potential drugs because of their structural 
complexity, limited tractability and availability.120 Enantiodivergent route to both 
enantiomers of β-santalene and also of epi-β-santalene were described by Takano and co-
workers121 starting from (S)-5-hydroxymethylbuten-2-olide,122 accessible from D-
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mannitol. This butanolide was heated in the presence of cyclopentadiene giving the endo-
cycloadduct, which was further transformed into the common precursor of ()- and (+)-
bicyclic lactones. Hydrolysis of the saturated lactone, followed by treatment of the 
resulting carboxylate with sodium periodate and then with NaBH4 in the same flask 
furnished the ()-lactone, precursor of (+)-β-santalene, in 66% overall yield (Scheme 73). 
On the other hand, the reduction of the starting lactone with LiAlH4 and subsequent 
oxidation of the alcohol to and aldehyde with NaIO4 and final oxidation to acid with 
Ag2CO3-Celite in refluxing benzene provided the (+)-lactone in 47% overall yield, direct 
precursor of ()-β-santalene. The common intermediate has been transformed into (+)- 
and ()-bicyclic dimethylenones precursors of (+)- and ()-epi-β-santalenes. All these 
sesquiterpenes are constituents of East Indian sandalwood oil.
OO
OHi. H2 20% NaOH, H2O, 0 ºC
ii. NaIO4
iii. NaBH4, 0 ºC to rt
i. LAH, THF, 0 ºC
ii. NaIO4
iii. Ag2CO3-Celite, PhH, heat
OO O
O
()-lactone
66% 47%
(+)-lactone
(+)--santalene ()--santalene
Scheme 73  Enantiodivergent routes to (+)- and ()-β-santalenes.
The same group described enantioselective routes to aromatic biasabolane 
sesquiterpenes (+)- and ()-α-curcumene from the epoxide obtained by Sharpless 
epoxidation of trans-4-methylcinnamate alcohol.123 This ()-3-(4-tolyl)glycidol was 
treated with lithium dimethylcyano cuprate to afford the corresponding diol in 73% yield 
(Scheme 74). This diol was further transformed into ()-α-curcumene. Alternatively, the 
glycidol was treated with trimethylaluminum providing the other diastereomeric diol 
precursor of (+)-α-curcumene.
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O
H
H
Me2Cu(CN)Li, Et2O,-40 ºC Me3Al, DCM. -72 ºC
OH
OH
OH
OH
73% 89%, dr = 97:3
(+)--curmene ()--curmene
Scheme 74  Enantiodivergent routes to (+)- and ()-α-curmenes.
α-Cuparenone is a sesquiterpene occurring in both enantiomeric forms in nature. 
Ogasawa and co-workers124 have reported enantiodivergent routes to ()- and (+)-α-
cuparenone from an acetonide obtained from ()-(cis-1,4)-4-cumyloxy-2-cyclopenten-1-
ol.125 Desilylation of the acetonide, followed by Dess-Martin oxidation, produced the 
corresponding ketone which, by reaction with MeLi in the presence of CeCl3, gave 
diastereoselectively the tertiary alcohol. Final deprotection of the cumyl group by 
hydrogenation provided the (+)-diol precursor of (+)-α-cuparenone (Scheme 75). On the 
other hand, hydrogenolysis of the starting acetonide, followed by oxidation, provided the 
corresponding ketone, which reacted with MeLi giving, after desilylation, the 
enantiomeric ()-diol precursor of ()-α-cuparenone.
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O O
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Scheme 75  Enantiodivergent routes to (+)- and ()-α-cuparenone.
Overman and co-workers126 reported enantiodivergent routes to (+)- and ()-
scopadulcic acid A, a diterpene isolated from Scoparia dulcis L., a perennial herb found 
in many tropical countries used as herbal remedy against a variety of disorders. Hayashi 
and co-workers have studied their pharmacological profile as antiviral127 and antitumor128 
activities. As common starting intermediate an ynone was employed, which was reduced 
to the (R)-alcohol with (R)-B-isopinocamphenyl-9-borabicyclo[3.3.1]nonane [(R)-
Alpine-Borane].129 This is a precursor of (+)-scopadulcic acid A (Scheme 76). Besides, 
the (S)-enantiomer was prepared using (S)-Alpine-Borane.
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Scheme 76  Enantiodivergent routes to (+)- and ()-scopadulcic acid A.
6. Conclusions
Enantio- and diastereodivergent routes to carbohydrates such as monosaccharides, 
carbasugars, aminosugars and azasugars are mainly based on protecting group strategies.  
Generally, other carbohydrates are used as starting materials.  Inversion of the 
configuration of hydroxy groups is carried out in two steps by sulfonation and SN2 
reaction or by direct Mitsunobu procedure. Alternatively, it was performed by two steps 
involving oxidation to a carbonyl group followed by diastereoselective reduction. In the 
case of unsaturated compounds epoxidation and hydroxylation methods are common 
stereodivergent routes. Diastereodivergent routes to acyclic α-amino acids can be mainly 
performed using Garner’s aldehyde. For heterocyclic α-AAs functional group 
transformations using pipecolic acid derivatives are involved in diastereodivergent routes. 
Structurally different β- and γ-AAs have been prepared diastereodivergently. 
Diastereomeric octahydroindole and isoindole phosphonic acids are accessible by 
diastereodivergent routes. The group of alkaloids, such as pyrrolidines, pyrrolizidines, 
piperidines, indolizidines, quinolizidines, decahydroquinolines and 
octahydroisoquinolines are mainly prepared through diastereodivergent multistep routes. 
Other alkaloids, such as balanol, vincamine, anatoxin and codeine have been prepared 
using enantiodivergent routes, whereas ()-epi- and tri-epi-isochaetominine C, ()-
galanthamine and epi-galanthamine were synthesized by means of diastereodivergent 
routes. Some enantiomeric sesquiterpenes such as β-santalene, α-curcumene and α-
cuparenone have been prepared through enantiodivergent routes as well as the diterpene 
scopadulcic acid A.
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AA: amino acid
Ac: acetyl
ACE: angiotensin-converting enzyme
AHPPA: 4-amino-3-hydroxy-5-phenylpentanoic acid 
AIBN: azobisisobutyronitrile
Alpine-Borane: B-isopinocanphenyl-9-borabicyclo[3.3.1]nonane
Ambersep 900 OH: strong basic anion exchange resin 
9-BBN: 9-borabicyclononane
BIRT-377: (5R)-5-[(4-bromophenyl)methyl]-3-(3,5-dichlorophenyl)-1,5-dimethyl-2,4-             
imidazolidinedione
Bn: benzyl
Boc: tert-butoxycarbonyl
Bu: butyl
Bz: benzoyl
18-C-6: 18-crown-6
CAN: cerium ammonium nitrate
cat: catalyst, catalytic amount
Cbz: benzyloxycarbonyl
CNS: central nervous system
Cy: cyclohexyl
DAST: diethylaminosulfur trifluoride
DBU: 1,8-diazabicycloundec-7-ene
DCE: 1,2-dichloroethane
DCM: dichloromethane
dDNJ: 1,6-dihydroxynojirimycin
DDQ: dichloro dicyano quinone
DEAD: diethyl azodicarboxylate
DIAD: diisopropyl azodicarboxylate
DIBALH: diisopropylaluminum hydride
DIC: diisopropylcarbodiimide
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DIPA: diisopropylamine
DIPEA: diisopropylethylamine 
DMAP: 4-dimethylaminopyridine
DMDP: 3,4-dihydroxy-2,5-bis(hydroxymethyl)pyrrolidine
DME: 1,2-dimethoxyethane
DMF: dimethylformamide
DMP: Dess-Martin periodinane
DMSO: dimethyl sulfoxide
Dowex: ion exchange resine
DPPA: diphenylphosphoryl azide
dppf: 1,1’-bis(diphenylphosphino)ferrocene 
Et: ethyl
Fmoc: 9-fluorenylmethyl
GABA: γ-aminobutyric acid
h: hour(s)
HMPA: hexamethylphosphoramide  
HWE: Horner-Wadsworth-Emmons
IBX: 2-iodoxybenzoic acid
Im: imidazol
IPA: isopropyl alcohol
KHMDS: potassium hexamethyldisilazide
KRI: key risk indicator
LAH: lithium aluminum hydride
LDA: lithium diisopropylamide
LFA-1: lynphocite function-associate antigen
LHMDS: lithium hexamethyldisilazide
L-Selectride: lithium tri-sec-butylborohydride
LTDM: lithium 2,2,6,6-tetramethylpiperidine
MCPBA: meta-chloroperbenzoic acid
Me: methyl
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MOM: methoxymethyl
Ms: mesyl, methanesulfonyl
MW: microwaves
NBA: N-bromoacetamide
NBS: N-bromosuccinimide
NMO: morpholine N-oxide
NN-DGJ: N-nonyl-1-deoxygalactonojirimycin
NN-DMJ: N-nonyl-1-deoxymannojirimycin
ox.: oxidation
PCC: pyridinium chlorochromate
PG: protecting group
Pd/C: palladium on carbon
PDC: pyridinium dichromate
Phth: phthalimidyl
PLE: porcine liver estearase
PMB: para-methoxybenzyl
PMP: para-methoxyphenyl
PPPA: diphenylphosphonyl azide
PPTS: pyridinium para-toluenesulfonate
Pr: propyl
PTSA: para-toluenesulfonic acid
Py: pyridine
quant: quantitative
Ra-Ni: Raney nickel
RedAl: sodium bis(2-methoxyethoxy)aluminum hydride
ref: reference
rt: room temperature
[Ru]: ruthenium complex
Su: succinimide
TBAB: tetrabutylammonium bromide
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TBAF: tetrabutylammonium fluoride
TBAI: tetrabutylammonium iodide
TBDPS: tert-butyldiphenylsilyl
TBS: tert-butyldimethylsilyl
tBu: tert-butyl
Tf: triflic, trifluoromethylsulfonyl
TFA: trifluoroacetic acid
THF: tetrahydrofuran
TIPS: triisopropylsilyl
TMEDA: tetramethylethylene diamine
TMO: trimethylamine N-oxide
Tp: hydrido-tris-pyrazolylborate
Trityl, Tr: triphenylmethyl
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